These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27705192)

  • 1. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.
    Shehadeh N; Raz I; Nakhleh A
    Cardiovasc Diabetol; 2018 Aug; 17(1):117. PubMed ID: 30134893
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin: a multitasking medication.
    Bailey CJ
    Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin and risk of cardiovascular disease.
    Turner RC; Holman RR
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin.
    Bloomgarden ZT
    Diabetes Care; 1995 Jul; 18(7):1078-80. PubMed ID: 7555549
    [No Abstract]   [Full Text] [Related]  

  • 6. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
    van Stee MF; de Graaf AA; Groen AK
    Cardiovasc Diabetol; 2018 Jun; 17(1):94. PubMed ID: 29960584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):699-704. PubMed ID: 33549430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novo Nordisk incretin and Cardiovascular Summit, Durban, June 2013.
    Wagenaar P
    Cardiovasc J Afr; 2013 Sep; 24(8):340. PubMed ID: 24240386
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?
    Psaty BM; Fleming TR
    Am J Hypertens; 2019 Sep; 32(10):927-929. PubMed ID: 31175821
    [No Abstract]   [Full Text] [Related]  

  • 11. Is metformin cardioprotective?
    Sasali A; Leahy JL
    Diabetes Care; 2003 Jan; 26(1):243-4. PubMed ID: 12502689
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.
    Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H
    Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
    Low Wang CC; Everett BM; Burman KD; Wilson PWF
    Circulation; 2019 Apr; 139(14):1741-1743. PubMed ID: 30933621
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin: the past, presence, and future.
    Alušík Š; Paluch Z
    Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose lowering strategies and cardiovascular disease in type 2 diabetes - teachings from the TOSCA.IT study.
    Vaccaro O; Masulli M; Riccardi G
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):722-726. PubMed ID: 29804832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.